Smart Powerr Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Smart Powerr Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $262.5K | Mar 31, 2026 |
| FY2020 | Dec 31, 2019 | $867.4K | Apr 15, 2021 |
| FY2017 | Dec 31, 2017 | $6.49M | Apr 8, 2019 |
| FY2017 | Dec 31, 2016 | $4.48M | Apr 8, 2019 |
| FY2016 | Dec 31, 2015 | $24.36M | Apr 8, 2019 |
| FY2015 | Dec 31, 2014 | $19.66M | Mar 29, 2016 |
| FY2014 | Dec 31, 2013 | $63.19M | Mar 23, 2015 |
| FY2013 | Dec 31, 2012 | $1.25M | Mar 24, 2014 |
| FY2011 | Dec 31, 2011 | $31.29M | Jul 18, 2013 |
| FY2011 | Dec 31, 2010 | $75.61M | Jul 18, 2013 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2015 | $24.08M | Mar 30, 2017 |
| FY2015 | Dec 31, 2014 | $18.87M | Mar 29, 2016 |
| FY2014 | Dec 31, 2013 | $62.01M | Mar 23, 2015 |
| FY2013 | Dec 31, 2012 | $0 | Mar 24, 2014 |
| FY2011 | Dec 31, 2011 | $30.11M | Jul 18, 2013 |
| FY2011 | Dec 31, 2010 | $74.28M | Jul 18, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $116.6K | Mar 31, 2026 |
| FY2017 | Dec 31, 2017 | $6.49M | Apr 8, 2019 |
| FY2017 | Dec 31, 2016 | $4.41M | Apr 8, 2019 |
| FY2016 | Dec 31, 2015 | $3.22M | Apr 8, 2019 |
| FY2015 | Dec 31, 2014 | $5.07M | Mar 29, 2016 |
| FY2014 | Dec 31, 2013 | $15.35M | Mar 23, 2015 |
| FY2013 | Dec 31, 2012 | $1.25M | Mar 24, 2014 |
| FY2011 | Dec 31, 2011 | $8.28M | Jul 18, 2013 |
| FY2011 | Dec 31, 2010 | $18.57M | Jul 18, 2013 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.90M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($1.56M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($746.8K) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($4.46M) | Apr 11, 2024 |
| FY2022 | Dec 31, 2021 | ($12.23M) | May 8, 2023 |
| FY2021 | Dec 31, 2020 | $4.05M | Sep 13, 2022 |
| FY2020 | Dec 31, 2019 | ($8.77M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($66.00M) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($7.34M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($48.30M) | Apr 8, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.02M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($1.09M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($798.5K) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($3.88M) | Apr 11, 2024 |
| FY2022 | Dec 31, 2021 | ($808.2K) | May 8, 2023 |
| FY2021 | Dec 31, 2020 | $5.83M | Sep 13, 2022 |
| FY2020 | Dec 31, 2019 | ($9.11M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($57.99M) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $5.81M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($45.86M) | Apr 8, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2023 | $200.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $650.0K | Mar 28, 2025 |
| FY2021 | Dec 31, 2021 | $1.00M | Sep 13, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $66.91M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($10.76M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($68.10M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($351.9K) | Apr 11, 2024 |
| FY2022 | Dec 31, 2021 | ($1.61M) | May 8, 2023 |
| FY2021 | Dec 31, 2020 | $82.25M | Sep 13, 2022 |
| FY2020 | Dec 31, 2019 | ($14.65M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $2.17M | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($285.1K) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $39.51M | Apr 8, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2020 | $1.9K | Sep 13, 2022 |
| FY2016 | Dec 31, 2015 | $19.8K | Apr 8, 2019 |
| FY2015 | Dec 31, 2014 | $2.2K | Mar 29, 2016 |
| FY2014 | Dec 31, 2013 | $23.3K | Mar 23, 2015 |
| FY2013 | Dec 31, 2012 | $1.8K | Mar 24, 2014 |
| FY2011 | Dec 31, 2011 | $7.7K | Jul 18, 2013 |
| FY2011 | Dec 31, 2010 | $82.0K | Jul 18, 2013 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $157.64M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $121.23M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $136.47M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $139.14M | Apr 11, 2024 |
| FY2022 | Dec 31, 2021 | $153.27M | May 8, 2023 |
| FY2021 | Dec 31, 2020 | $137.14M | Sep 13, 2022 |
| FY2020 | Dec 31, 2019 | $123.85M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $171.44M | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $231.55M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $210.68M | Apr 8, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.49M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $16.50M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $27.22M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $28.34M | Apr 11, 2024 |
| FY2022 | Dec 31, 2021 | $28.51M | May 8, 2023 |
| FY2021 | Dec 31, 2020 | $44.98M | Sep 13, 2022 |
| FY2020 | Dec 31, 2019 | $45.22M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $88.26M | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $76.51M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $57.24M | Apr 8, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $143.15M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $104.73M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $109.25M | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $110.79M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $124.76M | Apr 11, 2024 |
| FY2022 | Dec 31, 2020 | $92.15M | May 8, 2023 |
| FY2021 | Dec 31, 2019 | $78.63M | Sep 13, 2022 |
| FY2020 | Dec 31, 2018 | $86.72M | Apr 15, 2021 |
| FY2019 | Dec 31, 2017 | $155.51M | May 14, 2020 |
| FY2018 | Dec 31, 2016 | $153.57M | Apr 16, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($64.96M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($62.06M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($60.50M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($59.73M) | Apr 11, 2024 |
| FY2022 | Dec 31, 2021 | ($55.28M) | May 8, 2023 |
| FY2021 | Dec 31, 2020 | ($43.03M) | Sep 13, 2022 |
| FY2020 | Dec 31, 2019 | ($46.45M) | Apr 15, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $138.81M | May 8, 2023 |
| FY2022 | Dec 31, 2021 | $152.01M | May 8, 2023 |
| FY2020 | Dec 31, 2020 | $107.80M | Apr 15, 2021 |
| FY2020 | Dec 31, 2019 | $16.22M | Apr 15, 2021 |
| FY2020 | Dec 31, 2018 | $53.22M | Apr 15, 2021 |
| FY2019 | Dec 31, 2017 | $49.83M | May 14, 2020 |
| FY2018 | Dec 31, 2016 | $47.75M | Apr 16, 2019 |
| FY2017 | Dec 31, 2015 | $41.75M | Apr 8, 2019 |
| FY2016 | Sep 30, 2015 | $53.17M | Apr 8, 2019 |
| FY2016 | Jun 30, 2015 | $53.38M | Apr 8, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $22.20M | Apr 15, 2021 |
| FY2019 | Dec 31, 2019 | $20.77M | May 14, 2020 |
| FY2018 | Dec 31, 2018 | $48.37M | Apr 16, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 11, 2024 |
| FY2022 | Dec 31, 2021 | (2) | May 8, 2023 |
| FY2021 | Dec 31, 2020 | 1 | Sep 13, 2022 |
| FY2019 | Dec 31, 2019 | (5) | May 14, 2020 |
| FY2019 | Dec 31, 2018 | (76) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | (5) | Apr 8, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 11, 2024 |
| FY2022 | Dec 31, 2021 | (2) | May 8, 2023 |
| FY2021 | Dec 31, 2020 | 1 | Sep 13, 2022 |
| FY2019 | Dec 31, 2019 | (5) | May 14, 2020 |
| FY2019 | Dec 31, 2018 | (76) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | (5) | Apr 8, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20.95M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 7.39M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 7.96M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 7.39M | Apr 11, 2024 |
| FY2022 | Dec 31, 2021 | 7.04M | May 8, 2023 |
| FY2021 | Dec 31, 2020 | 3.18M | Sep 13, 2022 |
| FY2020 | Dec 31, 2019 | 2.03M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | 1.03M | May 14, 2020 |
| FY2018 | Dec 31, 2017 | 8.31M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | 8.31M | Apr 8, 2019 |